Fig. 2
From: Prognostic biomarker discovery based on proteome landscape of Chinese lung adenocarcinoma
Proteomic features of LUAD and non-tumor samples. A Principal component analysis for benign lung disease, NATs and LUAD samples. B Definition of LUAD related proteins, NAT and benign lung disease related proteins. C ORA pathway enrichment results for LRPs and NDRPs. D STRING protein–protein interaction network (top panel) and MCODE protein cluster analysis for LRPs (bottom panel)